MetaCap

Fortrea (FTRE) vs Personalis (PSNL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Fortrea (FTRE) has outperformed Personalis (PSNL) over the past year, gaining 70.2% versus a gain of 46.7%. Fortrea is the larger company by market cap ($1.79 billion vs $1.55 billion), about 1.2 times the size. Fortrea converts more of its revenue into profit, with a net margin of -36.2% versus -116.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FTRE+70.18%PSNL+46.66%
+147%+45%-57%
Nov 21, 20251 yearNov 20, 2026
FTRE-38.37%PSNL+582.78%
+823%+346%-130%
Jun 12, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FTRE versus PSNL key metrics
MetricFTREPSNL
Share price$18.55$14.27
Market cap$1.79B$1.55B
1-day change-7.94%-3.06%
YTD return+7.54%+79.27%
1-year return+70.18%+46.66%
5-year return—+2.00%
Forward P/E16.52—
EPS (TTM)$-0.73$-1.16
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.72B$69.65M
Revenue growth (YoY)+1.00%-17.69%
Net income (latest FY)$-986.20M$-81.27M
Gross margin18.50%22.65%
Operating margin-32.04%-126.43%
Net margin-36.21%-116.69%
52-week high$26.16$18.89
52-week low$8.55$4.96
Distance from 52-week high-29.09%-24.46%
Analyst consensusbuyhold
Avg. price target upside+27.39%+6.31%
Average volume1.69M2.49M
Shares outstanding96.50M108.40M
Employees14,000259
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FTRE has outperformed PSNL by 23.5 percentage points over the past year.
  • Fortrea is more profitable, keeping -36.2 cents of every revenue dollar as net income versus -116.7 cents for Personalis.
  • Fortrea grew revenue faster in its latest fiscal year (+1.00% vs -17.69%).

About Fortrea

FTRE stock →

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.

Health Care · Medical Specialities · 14,000 employees

About Personalis

PSNL stock →

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Health Care · Medical Specialities · 259 employees

FTRE vs PSNL FAQ

Which is bigger, Fortrea or Personalis?

Fortrea (FTRE) is larger, with a market capitalization of $1.79B compared with $1.55B for Personalis (PSNL).

Which stock has performed better over the past year, FTRE or PSNL?

FTRE returned +70.18% over the past 12 months, compared with +46.66% for PSNL (price return, excluding dividends). Past performance does not predict future results.

Are Fortrea and Personalis in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons